Key TakeawaysThe weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer. Tumor ...

DIY tirzepatide, internet detective work and insurance appeals: The lengths 3 people are going to for weight loss drugs "Not being on it is not an option." ...

A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with overweight or obesity, outperforming liraglutide and placebo. Brain ...

So, Pena got to work, researching alternative sources for the medication, eventually deciding to take a chance on an online platform that worked with compounded tirzepatide makers.

By Hugo Francisco de Souza A new clinical trial reveals tirzepatide’s ability to curb hunger and alter brain responses to food, marking a new era in obesity treatment. Study: Tirzepatide on ...

Eli Lilly says GIP/GLP-1 agonist tirzepatide can reduce the risk of diabetes in overweight, obese people with prediabetes.

How does tirzepatide work? Tirzepatide, or Mounjaro, is an anti-diabetic drug. It lowers which blood sugar levels and slows down how quickly food is digested.

FDA under fire: Data discrepancies uncovered in AstraZeneca approval trials Investigation finds evidence of serious misreporting, raising fresh doubts over the approval and decade long use of ...

Eli Lilly's dual GLP-1/GIP agonist tirzepatide has been shown to reduce the risk of worsening disease in people with heart failure and obesity in a phase 3 trial, the first to show a benefit on ...